BCG Vaccination Reaction
8
1
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
50%
4 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
Measles and BCG Vaccines for Mother and Child
A Study of GC3107(BCG Vaccine) in Healthy Infants
Safety and Tuberculin Conversion Following BCG Vaccination
BCG Vaccination Scar Formation in Children Under Five Years :Factors Affecting Its Formation and Subsequent Adverse Effects .
Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)
Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland